PYC Therapeutics Ltd (PYC) — Capital Reinvestment Ratio
Latest as of June 2017:
0.00x
PYC Therapeutics Ltd (PYC) has a Capital Reinvestment Ratio of 0.00x as of June 2017, meaning it reinvests 0% of its operating cash flow (AU$1.73 Million) in capital expenditures (AU$608.00). See PYC Therapeutics Ltd (PYC) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
AU$1.73 Million
AUD
Capital Expenditures
AU$608.00
AUD
Data as of
Jun 2017
Most recent filing
PYC Therapeutics Ltd Capital Reinvestment Ratio (2004–2004)
This chart tracks PYC Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for PYC Therapeutics Ltd (2004–2004)
Year-by-year Capital Reinvestment Ratio for PYC Therapeutics Ltd from 2004 to 2004. For live market cap and broader valuation context, see PYC Therapeutics Ltd (PYC) total market value.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2004 | 0.11x | AU$28.00K | AU$3.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow